FORA - Forian Inc. Stock Price, Fair Value and News

2.75USD+0.04 (+1.48%)Market Closed

Market Summary

USD2.75+0.04

Market Closed

1.48%

FORA Stock Price

View Fullscreen

FORA RSI Chart

FORA Valuation

Market Cap

85.6M

Price/Earnings (Trailing)

25.22

Price/Sales (Trailing)

4.18

EV/EBITDA

22.28

Price/Free Cashflow

-341.41

FORA Price/Sales (Trailing)

FORA Profitability

EBT Margin

14.29%

Return on Equity

12.79%

Return on Assets

5.91%

Free Cashflow Yield

-0.29%

FORA Fundamentals

FORA Revenue

Revenue (TTM)

20.5M

Rev. Growth (Yr)

0.14%

Rev. Growth (Qtr)

-9.16%

FORA Earnings

Earnings (TTM)

3.4M

Earnings Growth (Yr)

-118.66%

Earnings Growth (Qtr)

-187.3%

Breaking Down FORA Revenue

Last 7 days

5.0%

Last 30 days

3.4%

Last 90 days

5.0%

Trailing 12 Months

21.2%

How does FORA drawdown profile look like?

FORA Financial Health

Current Ratio

8.66

FORA Investor Care

Buy Backs (1Y)

4.43%

Diluted EPS (TTM)

0.11

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	20.5M	0	0	0
2023	17.8M	19.0M	20.1M	20.5M
2022	18.8M	17.8M	17.2M	16.4M
2021	2.1M	6.5M	11.3M	16.9M
2020	0	0	0	544.9K

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Forian Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 05, 2024	spaniel edward francis jr	sold (taxes)	-22,804	2.93	-7,783	evp, gen counsel & secretary
Feb 13, 2024	spaniel edward francis jr	sold (taxes)	-14,579	2.66	-5,481	evp, gen counsel & secretary
Feb 13, 2024	vesey michael	sold (taxes)	-13,092	2.66	-4,922	chief financial officer
Jan 12, 2024	spaniel edward francis jr	acquired	-	-	175,000	evp, gen counsel & secretary
Jan 12, 2024	vesey michael	acquired	-	-	175,000	chief financial officer
Oct 04, 2023	wygod martin j	bought	4,046	2.38	1,700	-
Sep 18, 2023	kassam-adams shahir	acquired	13,050	2.25	5,800	-
Sep 15, 2023	kassam-adams shahir	acquired	13,050	2.25	5,800	-
Sep 14, 2023	kassam-adams shahir	acquired	708	2.25	315	-
Sep 12, 2023	kassam-adams shahir	acquired	1,669	2.25	742	-

Which funds bought or sold FORA recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 16, 2024	Pineridge Advisors LLC	unchanged	-	4.00	33.00	-%
May 15, 2024	GOLDMAN SACHS GROUP INC	new	-	56,955	56,955	-%
May 15, 2024	Royal Bank of Canada	sold off	-100	-1,000	-	-%
May 15, 2024	ORACLE INVESTMENT MANAGEMENT INC	reduced	-0.9	499,683	4,501,280	2.99%
May 15, 2024	MILLENNIUM MANAGEMENT LLC	added	9.12	9,730	50,507	-%
May 15, 2024	Tower Research Capital LLC (TRC)	added	0.91	1,778	14,010	-%
May 15, 2024	Beaird Harris Wealth Management, LLC	unchanged	-	443	3,719	-%
May 15, 2024	BANK OF AMERICA CORP /DE/	reduced	-52.22	-1,902	2,254	-%
May 15, 2024	MORGAN STANLEY	new	-	10,252	10,252	-%
May 15, 2024	STATE STREET CORP	unchanged	-	21,274	178,809	-%

Are Funds Buying or Selling FORA?

Are funds buying FORA calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own FORA

No. of Funds

Unveiling Forian Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	feinberg larry n	5.79%	1,819,527	SC 13G/A
Feb 09, 2023	feinberg larry n	5.42%	1,788,110	SC 13G/A
Apr 14, 2022	feinberg larry n	5.17%	1,706,342	SC 13G
Feb 14, 2022	max wygod family dynasty trust	12.3%	4,015,795	SC 13G
Feb 14, 2022	spaniel edward francis jr	5.6%	1,831,526	SC 13G
Feb 14, 2022	dublin adam h	7.1%	2,321,027	SC 13G
Feb 14, 2022	coleman thomas jason	5.7%	1,910,147	SC 13G

Recent SEC filings of Forian Inc.

View All Filings

Date Filed	Form Type	Document
May 14, 2024	10-Q	Quarterly Report
May 14, 2024	8-K	Current Report
Apr 29, 2024	ARS	ARS
Apr 29, 2024	DEF 14A	DEF 14A
Apr 29, 2024	DEFA14A	DEFA14A
Mar 29, 2024	10-K	Annual Report
Mar 28, 2024	4	Insider Trading
Mar 28, 2024	4	Insider Trading
Mar 28, 2024	4	Insider Trading
Mar 28, 2024	4	Insider Trading

Peers (Alternatives to Forian Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	482.9B	379.5B	9.53%	9.48%	31.44	1.27	12.96%	-25.81%
CI	96.2B	206.0B	-2.11%	32.08%	24.97	0.47	12.55%	-43.95%
HCA	84.6B	66.7B	3.80%	15.55%	15.46	1.27	9.59%	-4.59%
CVS	72.4B	360.9B	-15.92%	-16.78%	9.89	0.2	9.07%	78.49%
CNC	41.7B	155.5B	8.44%	18.66%	15.24	0.27	6.34%	84.42%
DVA	12.3B	12.3B	9.53%	38.52%	15.03	0.99	5.77%	58.74%
UHS	11.9B	14.7B	11.04%	30.82%	14.63	0.81	7.99%	19.23%
MID-CAP
CHE	8.5B	2.3B	-6.47%	5.37%	30.15	3.73	5.96%	18.29%
ACHC	6.2B	3.0B	-5.49%	-7.73%	-545.12	2.06	10.92%	-104.06%
AMEH	2.3B	1.5B	9.06%	20.53%	36.62	1.57	19.34%	40.15%
AMN	2.2B	3.5B	4.01%	-38.44%	15.49	0.64	-27.67%	-62.43%
SMALL-CAP
ADUS	1.8B	1.1B	14.53%	25.72%	27.59	1.67	11.45%	30.74%
BKD	1.3B	3.0B	6.97%	85.25%	-7.66	0.44	4.98%	4.88%
BEAT	54.5M	-	-4.17%	-6.33%	-3.61	-	-	-1.05%
AMS	22.0M	21.6M	16.05%	23.93%	39.79	1.02	9.04%	-50.63%

Forian Inc. News

Latest updates

Forian Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1
Revenue	-9.2%	4,877,378	5,368,932	5,348,469	4,893,542	4,870,387	4,969,673	4,310,694	3,602,913	3,534,861	5,749,366	4,961,755	4,547,985	1,620,609	209,950	159,504	108,750	66,667
Costs and Expenses	5.9%	6,649,728	6,280,339	6,155,737	6,382,082	7,258,184	6,828,801	7,151,198	7,531,089	13,859,863	13,915,757	12,310,656	11,532,935	6,737,124	2,559,221	1,321,508	901,133	746,766
S&GA Expenses	-7.2%	1,055,141	1,137,536	1,313,212	1,237,327	1,196,192	1,044,668	1,080,660	1,003,104	820,594	1,277,977	1,088,203	1,177,035	598,975	422,590	40,217	55,978	55,066
R&D Expenses	27.0%	389,889	306,923	264,781	304,187	531,689	694,263	806,108	1,419,519	1,089,879	2,915,797	2,612,184	1,949,926	1,497,838	1,035,451	658,824	426,398	388,993
EBITDA Margin	39.2%	0.19	0.13	0.06	-0.38	-0.57	-1.11	-1.38	-1.53	-1.60	-1.44	-1.71	-2.17	-4.11	-9.12	-	-	-
Interest Expenses	-2.6%	198,963	204,238	211,333	210,758	208,456	213,059	213,060	208,648	211,333	232,006	79,422	-	-	-	-	-	-
Income Taxes	239.4%	102,540	-73,547	93,191	36,187	29,909	3,980	10,000	5,000	5,000	22,511	-	-	-	-	-	-	-
Earnings Before Taxes	-144.2%	-1,110,075	-454,561	5,546,834	-1,054,213	-2,218,890	-1,896,125	-2,956,053	-4,003,132	-10,312,700	-8,026,279	-7,021,722	-6,964,940	-4,515,653	-2,351,493	-1,161,915	-791,639	-675,136
EBT Margin	60.9%	0.14	0.09	0.02	-0.43	-0.62	-1.17	-1.47	-1.65	-1.72	-1.57	-1.84	-2.29	-4.20	-9.14	-	-	-
Net Income	-187.3%	-1,212,615	1,388,943	4,342,091	-1,122,826	6,498,479	-3,556,714	-5,127,624	-5,433,545	-11,854,088	-8,048,790	-7,021,722	-6,964,940	-4,515,653	-2,351,493	-1,161,915	-791,639	-675,136
Net Income Margin	-69.4%	0.17	0.54	0.31	-0.17	-0.43	-1.58	-1.77	-1.81	-1.80	-1.57	-1.84	-2.29	-4.20	-9.14	-	-	-
Free Cashflow	-268.3%	-2,208,070	-599,457	2,805,499	-248,798	-1,303,919	567,801	-3,409,891	-1,886,357	-3,900,405	-4,867,027	-5,318,749	-4,833,687	-3,672,841	-1,912,129	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet															(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2019Q4
Assets	-2.4%	57.00	59.00	59.00	55.00	56.00	46.00	48.00	51.00	54.00	57.00	60.00	41.00	33.00	13.00	-
Current Assets	-2.2%	56.00	57.00	58.00	55.00	55.00	27.00	28.00	29.00	33.00	36.00	40.00	21.00	12.00	13.00	0.00
Cash Equivalents	-83.0%	1.00	6.00	5.00	3.00	1.00	3.00	1.00	11.00	13.00	18.00	24.00	5.00	3.00	1.00	494*
Net PPE	-11.7%	0.00	0.00	0.00	0.00	0.00	0.00	3.00	3.00	2.00	2.00	1.00	0.00	0.00	0.00	0.00
Goodwill	-	-	-	-	-	-	9.00	9.00	9.00	9.00	9.00	9.00	9.00	9.00	-	-
Liabilities	-5.4%	31.00	33.00	32.00	35.00	35.00	34.00	34.00	33.00	33.00	32.00	30.00	7.00	7.00	1.00	-
Current Liabilities	-5.4%	6.00	7.00	7.00	9.00	10.00	8.00	8.00	8.00	8.00	7.00	6.00	6.00	6.00	1.00	0.00
Shareholder's Equity	1.4%	27.00	26.00	27.00	21.00	20.00	12.00	14.00	17.00	21.00	25.00	30.00	35.00	27.00	11.00	-
Retained Earnings	-2.5%	-48.90	-47.69	-49.07	-53.42	-52.29	-58.79	-55.24	-50.11	-44.67	-32.82	-24.77	-17.89	-10.76	-6.27	-1.29
Additional Paid-In Capital	2.1%	75.00	74.00	76.00	74.00	73.00	71.00	70.00	68.00	66.00	58.00	55.00	52.00	38.00	18.00	1.00
Shares Outstanding	0.7%	31.00	31.00	32.00	32.00	32.00	32.00	32.00	32.00	32.00	32.00	29.00	28.00	24.00	21.00	-
Float	-	-	-	-	40.00	-	-	-	83.00	-	-	-	236	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																		(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4
Cashflow From Operations	-268.3%	-2,208	-599	2,805	-248	-1,228	570	-3,409	-1,915	-3,825	-4,064	-5,006	-4,569	-3,608	-1,894	-837	-1,059	-458	-
Share Based Compensation	0.3%	1,659	1,653	1,552	1,540	1,828	1,340	1,593	1,374	7,614	3,055	2,628	2,754	864	8.00	9.00	7.00	5.00	-
Cashflow From Investing	-137.3%	-1,774	4,759	650	2,344	-633	1,546	-7,372	33.00	-667	-801	-204	-5,265	5,247	-11,521	1,266	1,177	-2,321	-
Cashflow From Financing	70.5%	-1,031	-3,493	-980	-32.76	-94.60	-29.32	-	-58.08	-13.12	-2.13	23,989	12,002	292	13,000	-	-	3,316	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

FORA Income Statement

2024-03-31

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]
Revenue	$ 4,877,378	$ 4,870,387
Costs and Expenses:
Cost of revenues	1,703,357	1,252,215
Research and development	389,889	531,689
Sales and marketing	1,055,141	1,196,192
General and administrative	3,492,454	3,639,826
Separation expenses	0	599,832
Depreciation and amortization	8,887	38,430
Total costs and expenses	6,649,728	7,258,184
Operating loss From Continuing Operations	(1,772,350)	(2,387,797)
Other Income (Expense):
Change in fair value of warrant liability	113	(5,559)
Interest and investment income	675,157	382,922
Gain on sale of investment	48,612	0
Interest expense	(198,963)	(208,456)
Gain on debt redemption	137,356	0
Total other income, net	662,275	168,907
Loss from continuing operations before income taxes	(1,110,075)	(2,218,890)
Income tax expense	(102,540)	(29,909)
Loss from continuing operations, net of tax	(1,212,615)	(2,248,799)
Loss from discontinued operations	0	(94,427)
Gain on sale of discontinued operations	0	11,531,849
Income tax effect on discontinued operations	0	(2,690,144)
Income from discontinued operations, net of tax	0	8,747,278
Net (Loss) Income	$ (1,212,615)	$ 6,498,479
Basic
Basic net (loss) income per share, continuing operations (in dollars per share)	$ (0.04)	$ (0.08)
Basic net (loss) income per share, discontinuing operations (in dollars per share)	0	0.27
Basic net (loss) income per share (in dollars per share)	(0.04)	0.19
Diluted
Diluted net (loss) income per share, continuing operations (in dollars per share)	(0.04)	(0.08)
Diluted net (loss) income per share, discontinuing operations (in dollars per share)	0	0.27
Net (loss) income per common share (in dollars per share)	$ (0.04)	$ 0.19
Weighted-average shares outstanding, basic (in shares)	30,999,433	32,300,237
Weighted-average shares outstanding, diluted (in shares)	30,999,433	32,300,237

FORA Balance Sheet

2024-03-31

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 1,029,128	$ 6,042,986
Marketable securities	46,405,857	42,296,589
Accounts receivable	4,267,782	2,572,931
Proceeds receivable from sale of discontinued operations, net	0	1,645,954
Contract assets	1,023,413	1,126,713
Prepaid expenses	868,525	1,077,233
Other current assets	2,437,222	2,515,509
Total current assets	56,031,927	57,277,915
Property and equipment, net	67,198	76,085
Right of use assets, net	5,395	10,664
Deposits and other assets	1,390,589	1,523,948
Total assets	57,495,109	58,888,612
Current liabilities:
Accounts payable	374,735	161,590
Accrued expenses and other current liabilities	3,235,544	4,252,257
Short-term operating lease liabilities	5,395	10,664
Warrant liability	450	563
Deferred revenues	2,852,454	2,413,551
Total current liabilities	6,468,578	6,838,625
Long-term liabilities:
Other long-term liabilities	500,000	1,000,000
Convertible notes payable, net of debt issuance costs (Note 11) ($6,000,000 in principal is held by a related party. Refer to Note 14)	23,981,788	24,870,181
Total long-term liabilities	24,481,788	25,870,181
Total liabilities	30,950,366	32,708,806
Commitments and contingencies (Note 16)
Stockholders' equity:
Preferred Stock; par value $0.001; 5,000,000 Shares authorized; 0 issued and outstanding as of March 31, 2024 and December 31, 2023	0	0
Common Stock; par value $0.001; 95,000,000 Shares authorized; 31,093,172 issued and outstanding as of March 31, 2024 and 30,920,450 issued and outstanding as of December 31, 2023	31,093	30,920
Additional paid-in capital	75,411,679	73,834,300
Accumulated deficit	(48,898,029)	(47,685,414)
Total stockholders' equity	26,544,743	26,179,806
Total liabilities and stockholders' equity	$ 57,495,109	$ 58,888,612

About Forian Inc.

Forian Inc. provides software and information solutions, proprietary data driven insights, and predictive analytics to optimize and measure the operational, clinical, and financial performance of its life science and healthcare customers. It operates through three segments: Information & Software, Services, and Other. The company's products include BioTrack, a vertically integrated point of sale, manufacturing, delivery, and cultivator software solution for dispensaries, cultivators, manufacturers, and distributors; and Cannalytics, a Software as a Service based analytics solution that provides customers with a presentation of business performance. Its products also comprise BioTrack seed-to-sale compliance traceability platform, which is used to manage the tracking and tracing of various cannabis products from cultivation to sale; and BioTrack State Traceability & Enforcement Monitoring System to ensure transparency and accountability throughout cannabis supply chain. In addition, the company offers security monitoring and web marketing services. Forian Inc. was incorporated in 2020 and is headquartered in Newtown, Pennsylvania. Forian Inc.

CEO	Mr. Max C. Wygod
WEBSITE	https://forian.com
INDUSTRY	Healthcare Plans
EMPLOYEES	102

Forian Inc. Frequently Asked Questions

What is the ticker symbol for Forian Inc.? What does FORA stand for in stocks?

FORA is the stock ticker symbol of Forian Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Forian Inc. (FORA)?

As of Fri May 17 2024, market cap of Forian Inc. is 85.63 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of FORA stock?

You can check FORA's fair value in chart for subscribers.

What is the fair value of FORA stock?

You can check FORA's fair value in chart for subscribers. The fair value of Forian Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Forian Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for FORA so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Forian Inc. a good stock to buy?

The fair value guage provides a quick view whether FORA is over valued or under valued. Whether Forian Inc. is cheap or expensive depends on the assumptions which impact Forian Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for FORA.

What is Forian Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, FORA's PE ratio (Price to Earnings) is 25.22 and Price to Sales (PS) ratio is 4.18. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. FORA PE ratio will change depending on the future growth rate expectations of investors.